SLSSELLAS Life Sciences Group, Inc.同业对比
SELLAS Life Sciences Group, Inc. 与SIC 2834 行业的逐项对比:市值、估值、增长、盈利能力、质量与总回报,以及在同业组内的排名。所有数值均由引擎从 SEC 申报与延迟行情计算,排名仅为组内排序位置 —— 描述性数据,非投资建议。
完整同业对比
同业组:同 SIC 行业分类 | 公司 | 市值 | 市盈率(TTM) | 市净率 | 市销率 | 营收同比增长 | 净利同比增长 | 息税前利润率 | 净资产收益率 | 投入资本回报率 | 皮氏 F 值 | 一年总回报 | 股息率 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SLS本股 | $2.1B#1 | — | 19.6x#1 | — | -100.0%#8 | 13.0%#4 | — | -25.0%#5 | — | — | 520.3%#1 | — |
| AARD | — | — | — | — | — | -179.7%#11 | — | -66.2%#8 | — | — | -54.1%#9 | — |
| ABBV | — | — | — | — | 8.6%#5 | -1.2%#8 | 24.6%#1 | — | 20.0%#1 | — | 39.3%#3 | — |
| ABCL | — | — | — | — | 160.6%#1 | 10.1%#5 | -289.0%#5 | -15.6%#4 | -25.2%#4 | — | 5.9%#5 | — |
| ABEO | — | — | — | — | — | -211.7%#12 | -1536.9%#7 | -49.1%#7 | -101.1%#7 | — | — | — |
| ABT | — | — | — | — | 5.7%#6 | -51.3%#9 | 18.2%#2 | 12.5%#2 | 8.3%#3 | — | -16.1%#7 | — |
| ABUS | — | — | — | — | 128.2%#2 | 52.1%#2 | -271.0%#4 | -12.9%#3 | — | — | — | — |
| ABVC | — | — | — | — | 48.0%#3 | -61.3%#10 | -2416.0%#8 | -73.4%#9 | -65.9%#6 | — | — | — |
| ABVX | — | — | — | — | — | — | — | — | — | — | 80.3%#2 | — |
| ACAD | — | — | — | — | 11.9%#4 | 73.0%#1 | 9.8%#3 | 31.3%#1 | 10.9%#2 | — | — | — |
| ACET | — | — | — | — | — | 0.3%#7 | — | -83.4%#11 | — | — | -36.3%#8 | — |
| ACIU | — | — | — | — | — | — | — | — | — | — | -8.8%#6 | — |
| ACRS | — | — | — | — | -58.2%#7 | 50.8%#3 | -975.9%#6 | -45.2%#6 | -60.8%#5 | 3#1 | — | — |
| ACRV | — | — | — | — | — | 3.3%#6 | — | -81.6%#10 | — | — | 15.1%#4 | — |
数值来自 SEC 申报与延迟行情;排名仅为该组内的排序位置 —— 描述性数据,不构成评级或建议。 本表构建超时,仅覆盖该组的一部分成员;排名仅相对于已列出的行,稍后会自动补全。 数据构建于 2026-07-26。
数据来自 SEC XBRL 申报与延迟行情 · 排名为组内排序 · 仅供参考 · 非投资建议